ESN-401

N/A

Report date: 2022/02/18 14:32:15
NME

Base Information

Drug NameESN-401
Drug Alias NameESN-401
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFree fatty acid receptor 2 antagonists
TargetsFree fatty acid receptor 2
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOgeda SA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOgeda SA
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus

Other Information

ATC CodeN/A
Related LinksN/A